By expenditures
| Name | Title | Type |
|---|---|---|
| Tina Cheney | EXECUTIVE DIRECTOR OF FINANCE | Auditee |
| Michael Slapnik | PARTNER | Auditee |
| Brian Anderson | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 365576 | 2024 | 2025-09-04 | Wipfli LLP | $19.80M |
| 321499 | 2023 | 2024-09-27 | Wipfli LLP | $20.87M |
| 29538 | 2022 | 2023-09-28 | Scott and Company LLC | $20.39M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 365576 | 2024 | 2025-09-04 | 1152032 | 2024-005 | Material Weakness | Yes | L |
| 365576 | 2024 | 2025-09-04 | 1152031 | 2024-004 | Significant Deficiency | - | A |
| 365576 | 2024 | 2025-09-04 | 1152030 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 1152029 | 2024-005 | Material Weakness | Yes | L |
| 365576 | 2024 | 2025-09-04 | 1152028 | 2024-003 | Material Weakness | Yes | I |
| 365576 | 2024 | 2025-09-04 | 1152027 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 1152026 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 1152025 | 2024-005 | Material Weakness | Yes | L |
| 365576 | 2024 | 2025-09-04 | 575590 | 2024-005 | Material Weakness | Yes | L |
| 365576 | 2024 | 2025-09-04 | 575589 | 2024-004 | Significant Deficiency | - | A |
| 365576 | 2024 | 2025-09-04 | 575588 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 575587 | 2024-005 | Material Weakness | Yes | L |
| 365576 | 2024 | 2025-09-04 | 575586 | 2024-003 | Material Weakness | Yes | I |
| 365576 | 2024 | 2025-09-04 | 575585 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 575584 | 2024-002 | Significant Deficiency | Yes | B |
| 365576 | 2024 | 2025-09-04 | 575583 | 2024-005 | Material Weakness | Yes | L |
| 321499 | 2023 | 2024-09-27 | 1075236 | 2023-008 | Significant Deficiency | - | L |
| 321499 | 2023 | 2024-09-27 | 1075235 | 2023-006 | Material Weakness | - | I |
| 321499 | 2023 | 2024-09-27 | 1075234 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075233 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075232 | 2023-009 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075231 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075230 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075229 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075228 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 1075227 | 2023-007 | Significant Deficiency | - | L |
| 321499 | 2023 | 2024-09-27 | 1075226 | 2023-006 | Material Weakness | - | I |
| 321499 | 2023 | 2024-09-27 | 1075225 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498794 | 2023-008 | Significant Deficiency | - | L |
| 321499 | 2023 | 2024-09-27 | 498793 | 2023-006 | Material Weakness | - | I |
| 321499 | 2023 | 2024-09-27 | 498792 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498791 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498790 | 2023-009 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498789 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498788 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498787 | 2023-005 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498786 | 2023-004 | Significant Deficiency | - | B |
| 321499 | 2023 | 2024-09-27 | 498785 | 2023-007 | Significant Deficiency | - | L |
| 321499 | 2023 | 2024-09-27 | 498784 | 2023-006 | Material Weakness | - | I |
| 321499 | 2023 | 2024-09-27 | 498783 | 2023-004 | Significant Deficiency | - | B |